Eriksson Mikael, Czene Kamila, Pawitan Yudi, Leifland Karin, Darabi Hatef, Hall Per
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, Stockholm, 171 77, Sweden.
Department of Radiology, South General Hospital, 118 83, Stockholm, Sweden.
Breast Cancer Res. 2017 Mar 14;19(1):29. doi: 10.1186/s13058-017-0820-y.
Most mammography screening programs are not individualized. To efficiently screen for breast cancer, the individual risk of the disease should be determined. We describe a model that could be used at most mammography screening units without adding substantial cost.
The study was based on the Karma cohort, which included 70,877 participants. Mammograms were collected up to 3 years following the baseline mammogram. A prediction protocol was developed using mammographic density, computer-aided detection of microcalcifications and masses, use of hormone replacement therapy (HRT), family history of breast cancer, menopausal status, age, and body mass index. Relative risks were calculated using conditional logistic regression. Absolute risks were calculated using the iCARE protocol.
Comparing women at highest and lowest mammographic density yielded a fivefold higher risk of breast cancer for women at highest density. When adding microcalcifications and masses to the model, high-risk women had a nearly ninefold higher risk of breast cancer than those at lowest risk. In the full model, taking HRT use, family history of breast cancer, and menopausal status into consideration, the AUC reached 0.71.
Measures of mammographic features and information on HRT use, family history of breast cancer, and menopausal status enabled early identification of women within the mammography screening program at such a high risk of breast cancer that additional examinations are warranted. In contrast, women at low risk could probably be screened less intensively.
大多数乳腺钼靶筛查项目并非个性化。为有效筛查乳腺癌,应确定个体患该疾病的风险。我们描述了一种可在大多数乳腺钼靶筛查单位使用且不会增加大量成本的模型。
该研究基于Karma队列,其中包括70877名参与者。在基线乳腺钼靶检查后的3年内收集乳腺钼靶图像。利用乳腺钼靶密度、计算机辅助检测微钙化和肿块、激素替代疗法(HRT)的使用、乳腺癌家族史、绝经状态、年龄和体重指数制定了预测方案。使用条件逻辑回归计算相对风险。使用iCARE方案计算绝对风险。
比较乳腺钼靶密度最高和最低的女性,密度最高的女性患乳腺癌的风险高出五倍。当在模型中加入微钙化和肿块时,高危女性患乳腺癌的风险比低风险女性高出近九倍。在完整模型中,考虑到HRT的使用、乳腺癌家族史和绝经状态,AUC达到0.71。
乳腺钼靶特征测量以及HRT使用、乳腺癌家族史和绝经状态信息能够在乳腺钼靶筛查项目中早期识别出患乳腺癌风险极高、需要进行额外检查的女性。相比之下,低风险女性可能可以进行强度较低的筛查。